Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients

Robbert J.C. Slebos, Elizabeth Livanos, Hyeon Woo Yim, Scott H. Randell, Alden M. Parsons, Frank C. Detterbeck, M. Patricia Rivera, Jack A. Taylor

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The identification of individuals who are at greatest risk of developing lung cancer would greatly improve diagnosis and possibly lead to early treatment. To study the use of karyotypes for this purpose, we used short-term human bronchial epithelial (hBE) cell cultures from nonsmokers, smokers, and lung cancer patients. Twenty-five metaphases were scored for hBE cell cultures obtained from 32 patients: 8 were nonsmokers, and 24 had a history of smoking (of whom 11 had had lung cancer surgery). The number of abnormal metaphases ranged from 0 to 4 per cell culture. No overall differences in the number of abnormal metaphases were observed between nonsmokers and smokers or between lung cancer patients and non-lung cancer patients. The most commonly observed abnormalities were structural changes in chromosome 1 (six cultures), loss of chromosome 17 (six cultures), and trisomy of chromosome 20 (three cultures). These specific alterations were found almost exclusively in patients with a history of tobacco smoking. The results did not indicate that general chromosomal abnormalities are a useful marker for tobacco smoke exposure or cancer risk.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalCancer Genetics and Cytogenetics
Volume159
Issue number2
DOIs
StatePublished - Jun 2005

Fingerprint

Dive into the research topics of 'Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patients'. Together they form a unique fingerprint.

Cite this